Sumitomo Densetsu Co.,Ltd.
Sumitomo Densetsu Co.,Ltd. (1949.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Sumitomo Densetsu Co.,Ltd. (1949.T), covering cash flow, earnings, and balance sheets.
Sumitomo Densetsu Co.,Ltd. (1949.T) Income Statement & Financial Overview
Analyze Sumitomo Densetsu Co.,Ltd.’s 1949.T earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $63.66B | $49.41B | $50.76B | $39.81B |
| Cost of Revenue | $51.97B | $42.57B | $43.55B | $35.07B |
| Gross Profit | $11.69B | $6.83B | $7.21B | $4.74B |
| Gross Profit Ratio | $0.18 | $0.14 | $0.14 | $0.12 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.70B | $3.10B | $2.89B | $2.89B |
| Operating Expenses | $3.70B | $3.10B | $2.89B | $2.89B |
| Total Costs & Expenses | $55.67B | $45.67B | $46.44B | $37.97B |
| Interest Income | $45.00M | $0.00 | $35.00M | $38.00M |
| Interest Expense | $11.00M | $0.00 | $8.00M | $8.00M |
| Depreciation & Amortization | $371.00M | $346.25M | $310.00M | $346.25M |
| EBITDA | $8.49B | $4.08B | $4.71B | $2.52B |
| EBITDA Ratio | $0.13 | $0.08 | $0.09 | $0.06 |
| Operating Income | $7.99B | $3.73B | $4.32B | $1.85B |
| Operating Income Ratio | $0.13 | $0.08 | $0.09 | $0.05 |
| Other Income/Expenses (Net) | $230.00M | $429.00M | $71.00M | $335.00M |
| Income Before Tax | $8.22B | $4.16B | $4.39B | $2.18B |
| Income Before Tax Ratio | $0.13 | $0.08 | $0.09 | $0.05 |
| Income Tax Expense | $2.40B | $1.36B | $1.27B | $782.00M |
| Net Income | $5.68B | $2.70B | $3.06B | $1.35B |
| Net Income Ratio | $0.09 | $0.05 | $0.06 | $0.03 |
| EPS | $161.57 | $76.71 | $87.02 | $38.31 |
| Diluted EPS | $161.57 | $76.71 | $87.02 | $38.31 |
| Weighted Avg Shares Outstanding | $35.18M | $35.18M | $35.22M | $35.29M |
| Weighted Avg Shares Outstanding (Diluted) | $35.18M | $35.18M | $35.22M | $35.29M |
The company's financials show resilient growth, with revenue advancing from $39.81B in Q1 2024 to $63.66B in Q4 2024. Gross profit remained healthy with margins at 18% in Q4 2024 compared to 12% in Q1 2024. Operating income hit $7.99B last quarter, sustaining a consistent 13% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $8.49B. Net income rose to $5.68B, while earnings per share reached $161.57. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan